Dyloject FDA Approval History
Marketing Status: Discontinued
Dyloject (diclofenac sodium injection) is an intravenous non-steroidal anti-inflammatory drug (NSAID) for the management of acute moderate-to-severe pain in adults.
Development Timeline for Dyloject
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.